Tower Research Capital LLC (TRC) - VIRIDIAN THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of VIRIDIAN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$140,391
+19.1%
9,152
+84.8%
0.00%0.0%
Q2 2023$117,832
+143597.6%
4,953
+53.9%
0.00%
+33.3%
Q1 2023$82
+1540.0%
3,218
+1874.2%
0.00%
Q4 2022$5
-100.0%
163
-98.0%
0.00%
-100.0%
Q3 2022$167,000
+406.1%
8,173
+189.0%
0.00%
+200.0%
Q2 2022$33,000
-26.7%
2,828
+14.1%
0.00%
Q1 2022$45,0002,478
+247700.0%
0.00%
Q4 2021$0
-100.0%
1
-99.2%
0.00%
Q1 2021$2,0001180.00%
Other shareholders
VIRIDIAN THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 944,092$15,530,0005.65%
Ally Bridge Group (NY) LLC 904,978$14,887,0004.38%
COMMODORE CAPITAL LP 667,674$10,983,0002.90%
FRAZIER MANAGEMENT LLC 1,505,200$24,761,0001.98%
Logos Global Management LP 1,500,000$24,675,0001.78%
Ghost Tree Capital, LLC 350,000$5,758,0001.68%
SILVERARC CAPITAL MANAGEMENT, LLC 106,078$1,745,0000.99%
Vivo Capital, LLC 1,300,000$21,385,0000.96%
ACUTA CAPITAL PARTNERS, LLC 135,807$2,234,0000.79%
BVF INC/IL 804,126$13,228,0000.52%
View complete list of VIRIDIAN THERAPEUTICS INC shareholders